Beyond beta blockers

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Blocking β-adrenergic receptors is a standard treatment for heart failure, but it limits the normal ability to modulate cardiac function. Targeting therapy further downstream by blocking activation of calcium-calmodulin-dependent protein kinase could provide an alternative.

Original languageEnglish (US)
Pages (from-to)379-380
Number of pages2
JournalNature Medicine
Issue number4
StatePublished - Apr 2005
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)


Dive into the research topics of 'Beyond beta blockers'. Together they form a unique fingerprint.

Cite this